Study finds possible alternative abortion pill
An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions


What happened
Researchers reported Thursday that a 60 milligram dose of ulipristal acetate, the active ingredient in the prescription emergency contraceptive Ella, appeared to be as safe and effective at ending a pregnancy as the abortion medication mifepristone.
The study, involving 133 women in the first nine weeks of pregnancy, was published in the journal NEJM Evidence.
Who said what
Dr. Beverly Winikoff, president of Gynuity Health Projects and lead author of the study, said abortion bans and efforts to bar mifepristone started her searching for more options. With the ulipristal and a later dose of misoprostol, "at least now we would have an alternative," she told The Associated Press.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Mifepristone, "now used in two-thirds of U.S. abortions," has been "under attack by abortion opponents" since Roe v. Wade was struck down, the AP said, and the new study "may make emergency contraception a target" as well. Drugmaker Perrigo said the prescribed 30 mg dose of Ella prevents but cannot end pregnancies. The "much more widely used morning-after pill" Plan B "contains a different drug and does not work in a way that would terminate a pregnancy, according to scientific evidence," The New York Times said.
What next?
The "political implications of the study are complex," the Times said. Evidence that a "morning-after pill ingredient can be used for abortion," as abortion opponents have long said, could "sow confusion" and "bolster the larger anti-abortion strategy," but banning contraception is deeply unpopular across the board.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Trump’s budget bill will increase the deficit. Does it matter?
Today's Big Question Analysts worry a 'tipping point' is coming
-
Film reviews: The Phoenician Scheme, Bring Her Back, and Jane Austen Wrecked My Life
Feature A despised mogul seeks a fresh triumph, orphaned siblings land with a nightmare foster mother, and a Jane fan finds herself in a love triangle
-
Music reviews: Tune-Yards and PinkPantheress
Feature "Better Dreaming" and "Fancy That"
-
A happy gut is a healthy gut. These 5 tips aim to help you achieve that goal.
The Week Recommends A healthy gut is all the rage in wellness circles
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
Women need more pain management during gynecological procedures
Under the radar Pain should no longer be ignored
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
Fly like a breeze with these 5 tips to help cope with air travel anxiety
The Week Recommends You can soothe your nervousness about flying before boarding the plane
-
RFK Jr.'s focus on autism draws the ire of researchers
In the Spotlight Many of Kennedy's assertions have been condemned by experts and advocates